BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27055227)

  • 1. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
    Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
    J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
    Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
    Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
    Lv MM; Fan XD; Su LX
    Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
    Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
    J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemangiomas: new insight and medical treatment.
    Neri I; Balestri R; Patrizi A
    Dermatol Ther; 2012; 25(4):322-34. PubMed ID: 22950559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience.
    Park YW; Yeom KB; Choi JW; Kim DY; Shin H; Kim KH
    J Dermatolog Treat; 2014 Oct; 25(5):391-5. PubMed ID: 23273264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Propranolol for Treating Hemangiomas in Infants with Previously Diagnosed Hypoglycemic Conditions.
    Yang TB; McMahon P; De Léon DD; Treat JR
    Pediatr Dermatol; 2016 Nov; 33(6):e381-e384. PubMed ID: 27574111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.